| __timestamp | AbbVie Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 35942000 |
| Thursday, January 1, 2015 | 6387000000 | 40028000 |
| Friday, January 1, 2016 | 5855000000 | 45853000 |
| Sunday, January 1, 2017 | 6275000000 | 53816000 |
| Monday, January 1, 2018 | 7399000000 | 60804000 |
| Tuesday, January 1, 2019 | 6942000000 | 77252000 |
| Wednesday, January 1, 2020 | 11299000000 | 45736000 |
| Friday, January 1, 2021 | 12349000000 | 50323000 |
| Saturday, January 1, 2022 | 15260000000 | 143526000 |
| Sunday, January 1, 2023 | 12872000000 | 149182000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of leading companies is crucial. AbbVie Inc. and Halozyme Therapeutics, Inc. present a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. AbbVie, a giant in the sector, has seen its SG&A expenses grow by approximately 66%, peaking in 2022. This reflects its aggressive expansion and marketing strategies. In contrast, Halozyme's SG&A expenses, though significantly smaller, have increased by over 300% during the same period, indicating its strategic investments in growth and development. This comparison not only highlights the differing scales and strategies of these companies but also underscores the dynamic nature of the pharmaceutical industry. As we move forward, these trends offer valuable insights into how these companies might continue to evolve.
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
Cost of Revenue Comparison: AbbVie Inc. vs Halozyme Therapeutics, Inc.
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Viatris Inc. and Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. and Apellis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Halozyme Therapeutics, Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated
Halozyme Therapeutics, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?